Work

In Search of Maximum Inspiratory and Expiratory Pressure Reference Equations

Year: 2009
Type: editorial
Abstract: Respiratory muscle weakness can occur in neuromus-cular diseases as well as in pulmonary disease. For exam-ple, in chronic obstructive pulmonary disease, patients’ muscles may become weakened from hyperinflation, which causes the diaphragm to function at a poor mechanical advantage, or in patients on steroids that can result in myopathies. Pulmonary function tests are used to deter-mine diagnosis, prognosis, and, when available, the effect of treatment. While vital capacity decreases in muscle weak-ness, and hypercapnia can be present, these measurements are both non-specific and occur after muscle strength is decreased by as much as half. In fact, we need to be able to differentiate limitations caused by parenchymal and air-way diseases from those attributable to the respiratory mus-cle weakness. While there are other specific tests to measure respira-tory muscle strength, determination of maximal inspira-tory pressure (MIP) and maximal expiratory pressure (MEP) can be performed routinely in a pulmonary func-tion laboratory, requiring only the minimum of equipment. These tests measure the overall muscle function and are carried out while the mouthpiece is closed so that the patient cannot inhale or exhale; lung volumes remain un-changed, so the performance of the muscles can be sepa-rated from the performance of the lung. A small leak pre-vents pressure from being generated by cheek muscles. However, pulmonary function tests must be standard-ized to be reliable, and any test result is only as good as the available reference values and lower limit of normal (LLN) values. Reference equations for MIP and MEP have been limited, and their use hampered by the variation in the techniques used.
Language: English
Field: Medicine
Open Access status: bronze
OpenAlex ID: W1909257044
Cites: 6
Cited by: 5
Related to: 10